FDA Inspection 1031818 — Ashland Specialty Ingredients, G.P.

Ashland Specialty Ingredients, G.P. — FEI 1000122243

The FDA completed an inspection of Ashland Specialty Ingredients, G.P. on Nov 21, 2017 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 21, 2017
Fiscal Year
2018
Product Type
Devices
Project Area
Radiation Control and Health Safety Act
Location
Bridgewater, NJ (United States)

Citations

IDCFRDescription
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
315921 CFR 820.184DHR content
367721 CFR 820.30(g)Design validation - software validation not performed
368321 CFR 820.70(g)Equipment Installation, Placement, Specified Requirements
369621 CFR 820.100(b)Documentation
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.